reference/27084270

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27084270

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	602
issn	1476-4679 1465-7392
issueIdentifier	5
pageRange	591-602
publicationName	Nature Cell Biology
startingPage	591
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3b8610d6493fb38e8d6b6f1e2348980a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3dc4aa6ecbdb2551ba03310de3917eac http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19865608560d15a957f5d0261e8c8d3e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a959f107252d40aa709c26f7d525106a
bibliographicCitation	Singh S, Kumar S, Srivastava RK, Nandi A, Thacker G, Murali H, Kim S, Baldeon M, Tobias J, Blanco MA, Saffie R, Zaidi MR, Sinha S, Busino L, Fuchs SY, Chakrabarti R. Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling. Nature Cell Biology. 2020 Apr 13;22(5):591–602. doi: 10.1038/s41556-020-0495-y.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6758-9276 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca49d594fed7dd947d3018a2cefcdb06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2adef8f369aaefdffc743807cfdaf978 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e65fb2dc7a21a76965b17589478cc896 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd46260e6350509c4423af034fe9d51b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5777-8479 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aab8226b3e5de3239998d2ce856a997b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e86e47cc3a34b2cd498102347834c95e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_684f3b406504441195339ca59aadd585 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9574-4576 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69907d7ca0984ba3743f75f922665bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19b8a37446ad15109fdcb28289e82f6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4404-2301 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9779805e22f7cdb720899bab74f727ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0136-5103 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7720-9660 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53a50ba20f5ca311cbf03a5eb65d7bfa
date	2020-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41556-020-0495-y https://pubmed.ncbi.nlm.nih.gov/PMC8237104 https://pubmed.ncbi.nlm.nih.gov/32284542
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21417 https://portal.issn.org/resource/ISSN/1476-4679 https://portal.issn.org/resource/ISSN/1465-7392
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling
discusses	http://id.nlm.nih.gov/mesh/M0293004 http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0298504 http://id.nlm.nih.gov/mesh/M0011490 http://id.nlm.nih.gov/mesh/M0026506 http://id.nlm.nih.gov/mesh/M000625118 http://id.nlm.nih.gov/mesh/M0006678
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f164b5bdd713c74bc4bd2b0bc727f5b2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b2dc6a4462c71b1b55d3dfe329f45ce1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2001 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55294 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3459

Total number of triples: 60.